Retinoblastoma protein expression in ovarian epithelial neoplasms

被引:8
作者
Niemann, TH [1 ]
Trgovac, TL
McGaughy, VR
Lewandowski, GS
Copeland, LJ
机构
[1] Ohio State Univ Hosp, Dept Pathol, Columbus, OH 43210 USA
[2] Ohio State Univ Hosp, Div Gynecol Oncol, Columbus, OH 43210 USA
[3] Arthur G James Canc Hosp & Res Inst, Columbus, OH 43210 USA
关键词
ovary; carcinoma; cystadenoma; low malignant potential; retinoblastoma;
D O I
10.1006/gyno.1998.5015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Progress has been made in identifying the molecular changes that occur in ovarian carcinoma; still our understanding of these changes and their interactions remains incomplete. In the present study the authors examined the expression of retinoblastoma protein, a tumor suppressor protein, in a spectrum of ovarian epithelial tumors including cystadenomas, low-malignant-potential tumors, and carcinomas. A heterogeneous pattern of reactivity was observed in all of the cystadenomas, in all of the low-malignant-potential tumors, and in a majority (27/34) of the carcinomas. The remaining carcinomas showed either a complete absence of reactivity or a pattern of altered reactivity characterized by areas of tumor with intact reactivity adjacent to zones of tumor with a complete absence of reactivity. There was no significant association between grade or stage and absent/altered reactivity. We conclude that alterations of retinoblastoma protein expression are uncommon in ovarian carcinoma. (C) 1998 Academic Press.
引用
收藏
页码:214 / 219
页数:6
相关论文
共 30 条
[1]  
BENDA JA, GOG PATHOLOGY MANUAL
[2]   AMPLIFICATION OF C-RAS-KI ONCOGENE IN HUMAN OVARIAN-TUMORS [J].
BOLTZ, EM ;
KEFFORD, RF ;
LEARY, JA ;
HOUGHTON, CR ;
FRIEDLANDER, ML .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (03) :428-430
[3]   PROMOTER DELETION AND LOSS OF RETINOBLASTOMA GENE-EXPRESSION IN HUMAN PROSTATE CARCINOMA [J].
BOOKSTEIN, R ;
RIO, P ;
MADREPERLA, SA ;
HONG, F ;
ALLRED, C ;
GRIZZLE, WE ;
LEE, WH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7762-7766
[4]  
CORDONCARDO C, 1994, AM J PATHOL, V144, P500
[5]  
DODSON MK, 1994, CANCER RES, V54, P610
[6]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[7]   ALTERATIONS OF THE RB GENE AND ITS ASSOCIATION WITH KI-RAS ACTIVATION AND P53 INACTIVATION IN ENDOMETRIAL ADENOCARCINOMA [J].
ENOMOTO, T ;
FUJITA, M ;
INOUE, M ;
NAKAZAWAMIYAMOTO, A ;
TANIZAWA, O ;
NOMURA, T .
MOLECULAR CARCINOGENESIS, 1993, 8 (03) :132-137
[8]   A HUMAN DNA SEGMENT WITH PROPERTIES OF THE GENE THAT PREDISPOSES TO RETINOBLASTOMA AND OSTEOSARCOMA [J].
FRIEND, SH ;
BERNARDS, R ;
ROGELJ, S ;
WEINBERG, RA ;
RAPAPORT, JM ;
ALBERT, DM ;
DRYJA, TP .
NATURE, 1986, 323 (6089) :643-646
[9]   ABERRANT RB GENE-EXPRESSION IN ROUTINELY PROCESSED, ARCHIVAL TUMOR-TISSUES DETERMINED BY 3 DIFFERENT ANTI-RB ANTIBODIES [J].
GERADTS, J ;
HU, SX ;
LINCOLN, CE ;
BENEDICT, WF ;
XU, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (02) :161-167
[10]  
Geradts J, 1996, MODERN PATHOL, V9, P339